Home/Lipidio Pharmaceuticals/David Bullough, Ph.D.

DB

David Bullough, Ph.D.

CSO

Lipidio Pharmaceuticals

Therapeutic Areas

Metabolic Cardiovascular Dermatology

Lipidio Pharmaceuticals Pipeline

Drug	Indication	Phase
GDD3898	Obesity	Phase 2

Leadership Team at Lipidio Pharmaceuticals

J. Gordon Foulkes, Ph.D.

View full Lipidio Pharmaceuticals profile